Dianthus Therapeutics (DNTH) Other Non Operating Income (2022 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Other Non Operating Income of -$360000.0 for Q3 2025, down 650.0% year-over-year from $65454.5 in Q3 2024, and down 236.45% quarter-over-quarter from -$107000.0 in Q2 2025.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Other Non Operating Income (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$360000.0 for Q3 2025.
- In Q3 2025, Other Non Operating Income fell 650.0% year-over-year to -$360000.0; the TTM figure through Sep 2025 stood at -$947000.0 (down 245.62% YoY), while the FY2024 annual figure was -$554000.0, down 551.76% from the prior year.
- Other Non Operating Income for Q3 2025 stood at -$360000.0, down from -$107000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $56000.0 in Q3 2022, with the low at -$382000.0 in Q4 2024.
- The 4-year median for Other Non Operating Income is -$48000.0 (2024), against an average of -$95230.8.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income tumbled 1166.67% in 2024, then grew 14.04% in 2025.
- Dianthus Therapeutics' Other Non Operating Income stood at -$20000.0 in 2022, then slumped by 60.0% to -$32000.0 in 2023, then slumped by 1093.75% to -$382000.0 in 2024, then rose by 5.76% to -$360000.0 in 2025.
- Business Quant data shows DNTH's Other Non Operating Income at -$360000.0 in Q3 2025, -$107000.0 in Q2 2025, and -$98000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Dianthus Therapeutics | 4.08 Bn | 3.67 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -360,000.00 |
| Jun 30, 2025 | -107,000.00 |
| Mar 31, 2025 | -98,000.00 |
| Dec 31, 2024 | -382,000.00 |
| Sep 30, 2024 | -48,000.00 |
| Jun 30, 2024 | -80,000.00 |
| Mar 31, 2024 | -114,000.00 |
| Dec 31, 2023 | -32,000.00 |
| Sep 30, 2023 | -16,000.00 |
| Jun 30, 2023 | -28,000.00 |
| Mar 31, 2023 | -9,000.00 |
| Dec 31, 2022 | -20,000.00 |
| Sep 30, 2022 | 56,000.00 |